Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, Massachusetts
- Most recent report
- 8-K, filed Aug 11, 2026
- Incorporated
- Delaware
- Filings on record
- 416 filings
- On EDGAR
- CIK 1819133
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 24
News 8 of 50
Prospectuses and Registrations 8 of 34
- 424B5 Prospectus supplement for an offering Aug 11, 2026
- 424B5 Prospectus supplement for an offering Jun 10, 2026
- FWP Free writing prospectus Jun 10, 2026
- 424B5 Prospectus supplement for an offering Jun 8, 2026
- S-8 Registration statement for an employee plan Mar 5, 2026
- S-3ASR Automatic shelf registration Nov 21, 2025
- S-3 Shelf registration statement Nov 21, 2025
- 424B5 Prospectus supplement for an offering Oct 24, 2025
Proxies 8 of 12
- DEFA14A Extra proxy material Apr 17, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 17, 2026
- DEFR14A Apr 24, 2025
- DEFA14A Extra proxy material Apr 22, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 21, 2025
- PRE 14A Preliminary proxy statement Apr 11, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
- PRE 14A Preliminary proxy statement Apr 17, 2024
Ownership 8 of 261
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 12, 2026
- 4 Insider reported a trade Aug 5, 2026
- 144 Notice of a proposed sale of restricted stock Aug 3, 2026
Other 8 of 35
- ARS Annual report sent to shareholders Apr 17, 2026
- EFFECT Notice that a registration became effective Dec 10, 2025
- CORRESP Reply to SEC staff Dec 8, 2025
- D Oct 28, 2025
- EFFECT Notice that a registration became effective May 21, 2025
- UPLOAD Comment letter from SEC staff May 20, 2025
- CORRESP Reply to SEC staff May 19, 2025
- ARS Annual report sent to shareholders Apr 22, 2025
Everything here comes from Tango Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.